CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.
Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .
Resultado final
List of partners identified in level of involvement.
Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 1 (se abrirá en una nueva ventana)Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting
AI-MEL Midterm recruitment report (se abrirá en una nueva ventana)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Report on molecular data collection of L/GCMN (se abrirá en una nueva ventana)Document detailing the results of molecular studies previously performed in L/GCMN
Standardized protocols and procedures for melanoma sub-classification (se abrirá en una nueva ventana)Document detailing the standardized protocols and procedures for melanoma sub-classification including staining, immunohistochemistry and molecular studies (FISH, NGS, others)
Immuno-Ped initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Standardized protocols for tumor tissue processing (se abrirá en una nueva ventana)Document detailing the standardized protocols for tumor tissue processing (inclusion, orientation of the sample, sectioning, etc)
Conclusions of common annual meeting of the ‘Understanding’ cluster 3 (se abrirá en una nueva ventana)Report on the conclusions of common annual meeting of the ‘Understanding’ cluster
Dissemination & communication plan 1 (se abrirá en una nueva ventana)Document describing the dissemination and communication plan
Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 3 (se abrirá en una nueva ventana)Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting
Project Management Plan (se abrirá en una nueva ventana)Document describing the management plan for MELCAYA project
Plan for ethic-legal monitoring & ethical submissions 1 (se abrirá en una nueva ventana)Document detailing the plan for ethic-legal monitoring & ethical submissions
Common work plan for scientific collaboration under the ‘Understanding’ cluster (se abrirá en una nueva ventana)Report on the common work plan for scientific collaboration under the ‘Understanding’ cluster
NevustoMel initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Immuno-Ped Midterm recruitment report (se abrirá en una nueva ventana)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Immuno-Ped II initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Patient engagement plan (se abrirá en una nueva ventana)Detailed plan for patient engagement
AI-MEL initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.AI-MEL study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project.
Mol-Mel Midterm recruitment report (se abrirá en una nueva ventana)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Plan for ethic-legal monitoring & ethical submissions 2 (se abrirá en una nueva ventana)Document detailing the plan for ethic-legal monitoring & ethical submissions
Conclusions of common annual meeting of the ‘Understanding’ cluster 1 (se abrirá en una nueva ventana)Report on the conclusions of common annual meeting of the ‘Understanding’ cluster
Dissemination & communication plan 2 (se abrirá en una nueva ventana)Document describing the dissemination and communication plan
Exploitation strategy (se abrirá en una nueva ventana)Document detailing the strategy for exploitation of the results
Precis-mel initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.The study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project. No further deliverables will be required.
Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 2 (se abrirá en una nueva ventana)Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting
NevustoMel Midterm recruitment report (se abrirá en una nueva ventana)Report when 50% of the study population is recruited. The report will include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Mid-term report on quality control (se abrirá en una nueva ventana)Document reporting quality issues identified and measures for correction.
Quality Assurance and Risk Management Plan (se abrirá en una nueva ventana)Document detailing the Quality Assurance and Risk Management Plan
ExpoMel initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Framework for assessing innovative HTs (se abrirá en una nueva ventana)Document describing the framework for assessing innovative Health technologies
Mol-Mel initiation package (se abrirá en una nueva ventana)- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.
Conclusions of common annual meeting of the ‘Understanding’ cluster 2 (se abrirá en una nueva ventana)Report on the conclusions of common annual meeting of the ‘Understanding’ cluster
Video and/or common cluster brochure of the projects included in the Mission Cancer Cluster 'Understanding'.
Project Website (se abrirá en una nueva ventana)MELCAYA webpage with public and private domains
Online and media presence 1 (se abrirá en una nueva ventana)Document with the summary of all on line MELCAYA post, citations and interactions
Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu
Data Management Plan 1 (se abrirá en una nueva ventana)Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu.
Data Management Plan 2 (se abrirá en una nueva ventana)Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu
Publicaciones
Autores:
Pietro Refolo; Costanza Raimondi; Violeta Astratinei; Livio Battaglia; Josep M. Borràs; Paula Closa; Alessandra Lo Scalzo; Marco Marchetti; Sonia Muñoz-López; Laura Sampietro-Colom; Dario Sacchini
Publicado en:
Healthcare, 2025, ISSN 2227-9032
Editor:
MDPI
DOI:
10.3390/HEALTHCARE13070829
Autores:
Mario Mandalà, Andrea Ferrari, Ines B. Brecht, Karijn PM Suijkerbuijk, Linda Maschke, Diana Giannarelli, Alice Indini, Martina Ubaldi, Giulia Pecci, Victoria Atkinson, Hildur Helgadottir, Stefano Chiaravalli, Naima Benannoune, Caroline Robert, Pawel Teterycz, Piotr Rutkowski, Susana Puig, Gabriele Madonna, Rejin Kebudi, Shirly Grynberg, Lidia MRB Arantes, Ewa Bien, Malgorzata Krawczyk, Maria Debora De Pasquale, Miranda P. Dierselhuis, Daniela Massi, Georgina V. Long, Paolo Antonio Ascierto, Alexander M.M. Eggermont
Publicado en:
European Journal of Cancer, Edición 211, 2024, ISSN 0959-8049
Editor:
Elsevier BV
DOI:
10.1016/J.EJCA.2024.114305
Autores:
Estefania Serra, Álvaro Abarzua-Araya, Ana Arance, Roberto Martin-Huertas, Francisco Aya, María Lourdes Olondo, Daniel Rizo-Potau, Josep Malvehy, Susana Puig, Cristina Carrera, Sebastian Podlipnik
Publicado en:
Cancers, 2024, ISSN 2072-6694
Editor:
MDPI
DOI:
10.3390/CANCERS16122272
Autores:
Indini, Alice; Didoné, Fabio; Massi, Daniela; Puig, Susana; Casadevall, Jordi Rubio; Bennett, Damien; Katalinic, Alexander; Sanvisens, Arantza; Ferrari, Andrea; Lasalvia, Paolo; Demuru, Elena; Ragusa, Rosalia; Mayer-da-Silva, Alexandra; Blum, Marcel; Mousavi, Mohsen; Kuehni, Claudia; Mihor, Ana; Mandalà, Mario; Trama, Annalisa
Publicado en:
European Journal of Cancer, 2024, ISSN 0959-8049
Editor:
Elsevier
DOI:
10.48620/77106
Autores:
E. Samaniego-González, S. Podlipnik, S. Ribero, E. Nagore, A. Boada, J. Cañueto, S. Paradela, B. de Unamuno, P. Rodríguez-Jiménez, S. Puig, J. Malvehy, C. Carrera, G. Roccuzzo, C. Requena, E. Manrique-Silva, N. Richarz, A. Ruiz-Villanueva, V. Traves, S. España-Fernández, R. Botella-Estrada, M.A. González-Morán, A. Tejera-Vaquerizo
Publicado en:
Actas Dermo-Sifiliográficas, Edición 116, 2025, ISSN 0001-7310
Editor:
Elsevier BV
DOI:
10.1016/J.AD.2024.07.017
Autores:
Samaniego-González, E.; Podlipnik, S.; Ribero, S.; Nagore, E.; Boada, A.; Cañueto, J.; Paradela, S.; de Unamuno, B.; Rodríguez-Jiménez, P.; Puig, S.; Malvehy, J.; Carrera, C.; Roccuzzo, G.; Requena, C.; Manrique-Silva, E.; Richarz, N.; Ruiz-Villanueva, A.; Traves, V.; España-Fernández, S.; Botella-Estrada, R.; González-Morán, M. A.; Tejera-Vaquerizo, A.
Publicado en:
Actas Dermo-Sifiliográficas, 2025, ISSN 0001-5555
Editor:
Taylor & Francis
DOI:
10.1016/J.AD.2024.07.017
Autores:
Pietro Refolo; Costanza Raimondi; Livio Battaglia; Josep M. Borràs; Paula Closa; Alessandra Lo Scalzo; Marco Marchetti; Sonia Muñoz López; Joan Prades Perez; Laura Sampietro-Colom; Dario Sacchini
Publicado en:
Healthcare, 2025, ISSN 2227-9032
Editor:
MDPI
DOI:
10.3390/HEALTHCARE13030321
Autores:
Estefania Serra; Álvaro Abarzua-Araya; Ana Arance; Roberto Martin-Huertas; Francisco Aya; María Lourdes Olondo; Daniel Rizo-Potau; Josep Malvehy; Susana Puig; Cristina Carrera; Sebastian Podlipnik
Publicado en:
Cancers, 2024, ISSN 2072-6694
Editor:
MDPI
DOI:
10.3390/CANCERS16122272
Autores:
Elise Marechal, Patrice Quintana, Daniel Aldea, Grégoire Mondielli, Nathalie Bernard-Marissal, Mathias Moreno, Valérie Delague, Lauren A. Weiss, Anne Barlier, Heather C. Etchevers
Publicado en:
bioRxiv, 2024, ISSN 1531-6386
Editor:
bioRxiv
DOI:
10.1101/2024.04.24.590951
Autores:
J. Angel-Baldo, S. Podlipnik, A. Azón, A. Boada, A. Arrieta, J. Marcoval, C. López-Sánchez, M. Sàbat, S. Segura, D. Bodet, N. Curcó, D. Lopez-Castillo, J. Solà, M. Quintana-Codina, C. Baliu-Piqué, M. Just-Sarobé, S. Martín-Sala, J. Malvehy, S. Puig, C. Carrera, R.M. Marti, Clara Matas-Nadal, Xavier Soria, Sonia Gatius, Felip Vilardell, Inma Gil, Cristina Grau, Fani Martínez, Nelson Lobos, Oriol Yélamos, Joan Dalmau, Carlos González-Cruz, Helena Hilari, Paola Pasquali, Marc Sagristà, María Rosa Olivella-Garcés, Montserrat Bonfill-Ortí, Josep Ramón Ferreres, Ane Jaka, Ariadna Quer, Nina Richarz, Inés Zarzoso Muñoz, Emili Masferrer, Pedro Zaballos, Manel Formigon, Loida Galvany, Marta Alegre, Anna Sánchez-Puigdollers, Nerea Mohino-Farré
Publicado en:
Actas Dermo-Sifiliográficas, Edición 116, 2025, ISSN 0001-7310
Editor:
Elsevier BV
DOI:
10.1016/J.AD.2024.10.060
Autores:
Daniel Aldea, Nicolas Macagno, Elise Marechal, Mathias Moreno, Pauline Romanet, Morgane Pertuit, Jérémy Garcia, Nathalie Degardin, Stéphanie Mallet, Isabelle James, Guillaume Captier, Anne Barlier, Heather C. Etchevers
Publicado en:
Journal of Investigative Dermatology, Edición 145, 2025, ISSN 0022-202X
Editor:
Elsevier BV
DOI:
10.1016/J.JID.2024.10.595
Autores:
Dario Di Gangi, Roberta Gugliotta, Filippo Ugolini, Anna Szumera-Ciećkiewicz, Llucia Alos, Natalia Castrejón, Stephan Forchhammer, Barbara Valeri, Nicolas Macagno, Sule Ozturk Sari, Ozge Hurdogan, Sokol Sina, Sylvie Fraitag, Valerio Gaetano Vellone, Chiara Trambaiolo, Rita Alaggio, Sabrina Rossi, Giovanni Arcuri, Daniela Massi, Claudio Conti
Publicado en:
EJC Skin Cancer, Edición 3, 2025, ISSN 2772-6118
Editor:
Elsevier BV
DOI:
10.1016/J.EJCSKN.2025.100742
Autores:
Baron, Roni; Haick, Hossam
Publicado en:
ACS Sensors, 2024, ISSN 2379-3708
Editor:
American Chemical Society (ACS)
DOI:
10.1021/ACSSENSORS.4C00636
Autores:
Alexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, Hannah Wild, Michael Abele, Axel Gschwind, Olga Seibel-Kelemen, Christian Seitz, Irina Bonzheim, Olaf Riess, German Demidov, Marc Sturm, Malou Schadeck, Michaela Pogoda, Ewa Bien, Malgorzata Krawczyk, Eva Jüttner, Thomas Mentzel, Maja Cesen, Elke Pfaff, Michal Kunc, Stephan Forchhammer, Andrea Forschner, Ulrike Leiter-Stöppke, Thomas K. Eigentler, Dominik T. Schneider, Christopher Schroeder, Stephan Ossowski, Ines B. Brecht
Publicado en:
eBioMedicine, Edición 96, 2023, ISSN 2352-3964
Editor:
Elsevier BV
DOI:
10.1016/J.EBIOM.2023.104797
Autores:
Javier Gil-Lianes; Victoria Amat-Samaranch; Priscila Giavedoni; Antoni Vilaseca; Julián Córdoba Sánchez; Francesc Alamon-Reig; Paola Castillo; Adriana P. Garcia; Mariona Pascal; Cristina Carrera
Publicado en:
Acta Dermato-Venereologica, 2024, ISSN 1651-2057
Editor:
Medical Journals Sweden
DOI:
10.2340/ACTADV.V104.40719
Autores:
Àngel-Baldó, Joan; Segura Tigell, Sonia; Network of Melanoma Centers of Catalonia
Publicado en:
instname:Universitat Pompeu Fabra, 2025, ISSN 0001-7310
Editor:
Actas Dermo-Sifiliográficas
DOI:
10.1016/J.AD.2024.10.060
Autores:
Alexandra Liebmann; Jakob Admard; Sorin Armeanu-Ebinger; Hannah Wild; Michael Abele; Axel Gschwind; Olga Seibel-Kelemen; Christian Seitz; Irina Bonzheim; Olaf Riess; German Demidov; Marc Sturm; Malou Schadeck; Michaela Pogoda; Ewa Bien; Malgorzata Krawczyk; Eva Jüttner; Thomas Mentzel; Maja Cesen; Elke Pfaff; Michal Kunc; Stephan Forchhammer; Andrea Forschner; Ulrike Leiter-Stöppke; Thomas K. Eigentler; Dominik T. Schneider; Christopher Schroeder; Stephan Ossowski; Ines B. Brecht
Publicado en:
eBioMedicine, Edición Elsevier, 2023, ISSN 2352-3964
Editor:
Elsevier BV
DOI:
10.1016/J.EBIOM.2023.104797
Autores:
Mandalà, Mario; Ferrari, Andrea; Brecht, Ines B.; Suijkerbuijk, Karijn PM; Maschke, Linda; Giannarelli, Diana; Indini, Alice; Ubaldi, Martina; Pecci, Giulia; Atkinson, Victoria; Helgadottir, Hildur; Chiaravalli, Stefano; Benannoune, Naima; Robert, Caroline; Teterycz, Pawel; Rutkowski, Piotr; Puig, Susana; Madonna, Gabriele; Kebudi, Rejin; Grynberg, Shirly; Arantes, Lidia MRB; Bien, Ewa; Krawczyk, Malgorzata; Pasquale, Maria Debora De; Dierselhuis, Miranda P.; Massi, Daniela; Long, Georgina V.; Ascierto, Paolo Antonio; Eggermont, Alexander M. M.
Publicado en:
European Journal of Cancer, 2024, ISSN 0959-8049
Editor:
Pergamon Press Ltd.
DOI:
10.1016/J.EJCA.2024.114305
Autores:
Alice Indini, Fabio Didoné, Daniela Massi, Susana Puig, Jordi Rubio Casadevall, Damien Bennett, Alexander Katalinic, Arantza Sanvisens, Andrea Ferrari, Paolo Lasalvia, Elena Demuru, Rosalia Ragusa, Alexandra Mayer-da-Silva, Marcel Blum, Mohsen Mousavi, Claudia Kuehni, Ana Mihor, Mario Mandalà, Annalisa Trama
Publicado en:
European Journal of Cancer, Edición 213, 2024, ISSN 0959-8049
Editor:
Elsevier BV
DOI:
10.1016/J.EJCA.2024.115079
Autores:
Heather C. Etchevers
Publicado en:
Pigment Cell and Melanoma Research, 2025
Editor:
Wiley
DOI:
10.1111/PCMR.70045
Autores:
Daniel Aldea, Israa Fakih, Nicolas Macagno, Mathias Moreno, Anne Barlier, Heather C. Etchevers
Publicado en:
Pigment Cell and Melanoma Research, 2025
Editor:
Wiley
DOI:
10.1111/PCMR.70045
Buscando datos de OpenAIRE...
Se ha producido un error en la búsqueda de datos de OpenAIRE
No hay resultados disponibles